Ara
Toplam kayıt 2, listelenen: 1-2
Patients eligible for modulator drugs: Data from cystic fibrosis registry of Turkey
(Wiley, 9999)
Background A better understanding of cystic fibrosis transmembrane conductance regulator biology has led to the development of modulator drugs such as ivacaftor, lumacaftor-ivacaftor, tezacaftor-ivacaftor, and elexacafto ...
Clinical features and accompanying findings of Pseudo-Bartter Syndrome in cystic fibrosis
(Wiley, 9999)
Background Pseudo-Bartter syndrome (PBS) is a rare complication of cystic fibrosis (CF) and there are limited data in the literature about it. We aimed to compare clinical features and accompanying findings of patients ...